Clinical Trial: A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748637) titled 'A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis' on July 29.

Brief Summary: This is a single-arm, open-label, dose-escalation clinical trial intended to evaluate the safety, efficacy and cellular pharmacokinetics of GT802 for the treatment of relapsing/refractory multiple sclerosis.

Study Start Date: Aug. 15

Study Type: INTERVENTIONAL

Condition: Multiple Sclerosis (MS)

Intervention: BIOLOGICAL: GT802 Injection

GT802 Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Daishi Tian

Information provided by (Responsible Party): Daishi Tian,...